In 66 adults with moderately active PsA on stable therapy, a 12-week multispecies probiotic was not superior to placebo: low disease activity or remission in 43% vs 65% of 56 analysed (OR 0.4, 95% CI 0.13–1.18; P=0.167), with no gut microbiome or permeability changes.
RCTn = 66
Bosch et al. Efficacy and safety of probiotic supplementation in PsA-a randomized controlled trial